Answers are grounded in this paper and cite their sources.
Cardiogenic shock (CS) is a life-threatening condition associated with significant morbidity and mortality. Pharmacological therapy is often the first line of treatment but mechanical support can provide substantial hemodynamic improvement in refractory CS. Percutaneous mechanical support devices are placed in a minimally invasive manner and provide life-saving assistance to the failing myocardium. We review the percutaneous devices currently available, the evidence behind their use, and the new advances in percutaneous technology being evaluated for the treatment of CS.
No takes yet. Share an insight, caveat, or question.
Gilani et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: